אינפיניפלקס בע"מ

אינפיניפלקס, חברת סטארט-אפ המפתחת בדיקה זולה, אמינה ולא פולשנית למעקב אחרי יעילות טיפולים במחלת הסרטן.

Infiniplex is developing advanced liquid biopsy solutions for precision oncology. Its core platform, InfiniplexDX, is designed to enable rapid, sensitive, and accessible mutation detection. By combining proprietary, ultra-high-performance primer design with widely available PCR infrastructure, InfiniplexDX enables rapid, highly sensitive and specific detection of target mutations in blood and urine samples.

HMO's, Clinical laboratories, hospitals, oncology centers, healthcare providers, organizations, performing molecular cancer diagnostics and precision-oncology testing.

Alon Shalev - CEO

Zeev Russak - CTO & Co-Founder